{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:24:36Z","timestamp":1757705076242},"reference-count":14,"publisher":"Europa Digital & Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.4244\/eijv12i1a19","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T13:57:48Z","timestamp":1463147868000},"page":"112-118","source":"Crossref","is-referenced-by-count":4,"title":["Appraising the safety and efficacy profile of left atrial appendage closure in 2016 and the future clinical perspectives. Results of the EAPCI LAAC survey"],"prefix":"10.4244","volume":"12","author":[{"given":"Andrea","family":"Santucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Baumbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roisin","family":"Colleran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Haude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Valgimigli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2774","reference":[{"key":"key-20165882038-0","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.","volume":"22","author":"Wolf PA.","year":"1991","journal-title":"Stroke."},{"key":"key-20165882038-1","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.","volume":"367","author":"Connolly S.","year":"2006","journal-title":"Lancet."},{"key":"key-20165882038-2","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation.","volume":"361","author":"Connolly SJ.","year":"2009","journal-title":"N Engl J Med."},{"key":"key-20165882038-3","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.","volume":"365","author":"Patel MR.","year":"2011","journal-title":"N Engl J Med."},{"key":"key-20165882038-4","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation.","volume":"364","author":"Connolly SJ.","year":"2011","journal-title":"N Engl J Med."},{"key":"key-20165882038-5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0735-1097(94)90743-9","article-title":"Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk.","volume":"23","author":"Mugge A.","year":"1994","journal-title":"J Am Coll Cardiol."},{"key":"key-20165882038-6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1161\/CIRCIMAGING.112.000153","article-title":"Detection of left atrial appendage thrombus by cardiac computed tomo?graphy in patients with atrial fibrillation: a meta-analysis.","volume":"6","author":"Romero J.","year":"2013","journal-title":"Circ Cardiovasc Imaging."},{"key":"key-20165882038-7","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.","volume":"33","author":"Camm AJ.","year":"2012","journal-title":"Eur Heart J."},{"key":"key-20165882038-8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.","volume":"374","author":"Holmes DR.","year":"2009","journal-title":"Lancet."},{"key":"key-20165882038-9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.","volume":"64","author":"Holmes DR Jr.","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"key-20165882038-10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.amjcard.2014.11.011","article-title":"Overview of the Food and Drug Administration circulatory system devices panel meetings on WATCHMAN left atrial appendage closure therapy.","volume":"115","author":"Waksman R.","year":"2015","journal-title":"Am J Cardiol."},{"key":"key-20165882038-11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ijcard.2014.03.154","article-title":"Left atrial appendage occlusion: initial experience with the Amplatzer\u2122 Amulet\u2122.","volume":"174","author":"Freixa X.","year":"2014","journal-title":"Int J Cardiol."},{"key":"key-20165882038-12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s00392-015-0828-1","article-title":"Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation.","volume":"104","author":"Gloekler S.","year":"2015","journal-title":"Clin Res Cardiol."},{"key":"key-20165882038-13","first-page":"34","article-title":"Side-by-Side Comparison of LAA Occlusion Performance With the Amplatzer Cardiac Plug and Amplatzer Amulet.","volume":"28","author":"Abualsaud A.","year":"2016","journal-title":"J Invasive Cardiol."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T13:57:59Z","timestamp":1463147879000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/98th_issue\/19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["EIJV12I1A19"],"URL":"https:\/\/doi.org\/10.4244\/eijv12i1a19","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}